February 4, 2019
Sosei on February 4 launched its oropharyngeal candidiasis treatment Oravi (miconazole), a novel once-daily mucoadhesive tablet formulation of the antifungal agent miconazole, in Japan. The drug, known as Loramyc/Oravig overseas, was developed by French drug maker BioAlliance Pharma SA and...read more